ÂÜÀòÂÒÂ×

John Bluth is the Chief Communications Officer at BioCryst Pharmaceuticals, Inc., where John oversees communications for the company's novel oral medicines for rare diseases. With a background in investor relations and corporate communications in the healthcare and technology industries, John has held executive roles at companies like Cempra Pharmaceuticals and PowerSecure. John also has experience in communications consulting and has worked with firms like JDB Communications, LLC. John holds a BA in Biology from Cornell University.